{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:05:29Z","timestamp":1794618329851,"version":"4.9.1"},"reference-count":126,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.survophthal.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:58:03Z","timestamp":1777647483000},"page":"1631-1640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optical coherence tomography biomarkers in patients with diabetic macular edema treated with dexamethasone implants"],"prefix":"10.1016","volume":"71","author":[{"given":"Maria Vittoria","family":"Cicinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1749-2737","authenticated-orcid":false,"given":"Luisa","family":"Frizziero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Sarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Cennamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Marsico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Di Fino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Gallinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.survophthal.2026.04.004_bib1","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1097\/IAE.0000000000001070","article-title":"Hyperreflective foci as an independent visual outcome predictor in macular edema due to retinal vascular diseases treated with intravitreal dexamethasone or ranibizumab","volume":"36","author":"Chatziralli","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.04.004_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8164250","article-title":"Role of inflammation in classification of diabetic macular edema by optical coherence tomography","volume":"2019","author":"Chung","year":"2019","journal-title":"J Diabetes Res"},{"issue":"7","key":"10.1016\/j.survophthal.2026.04.004_bib3","article-title":"The role of laser photocoagulation in treating diabetic macular edema in the era of intravitreal drug administration: A Descriptive Review","volume":"59","author":"Nozaki","year":"2023","journal-title":"Med"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/11206721221094786","article-title":"Deep learning algorithms for detection of diabetic macular edema in OCT images: A Systematic Review and Meta-analysis","volume":"33","author":"Li","year":"2023","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.04.004_bib5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/bjo-2024-325665","article-title":"Biomarkers of risk of switching to dexamethasone implant for the treatment of diabetic macular oedema in real clinical practice: A Multicentric Study","volume":"109","author":"Ruiz-Medrano","year":"2025","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.004_bib6","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s40123-024-00925-y","article-title":"Enhancing diabetic macular edema treatment outcomes: Exploring the ESASO Classification and Structural OCT Biomarkers","volume":"13","author":"Panozzo","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2147\/OPTH.S4033","article-title":"Cystoid macular edema","volume":"2","author":"Rotsos","year":"2008","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.004_bib8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0039-6257(04)00109-2","article-title":"Macular edema","volume":"49","author":"Tranos","year":"2004","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.survophthal.2024.07.006","article-title":"Role of inflammation in diabetic macular edema and neovascular age-related macular degeneration","volume":"69","author":"Vujosevic","year":"2024","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.004_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00592-019-01424-4","article-title":"Diabetic macular edema with neuroretinal detachment: OCT and OCT-Angiography Biomarkers of Treatment Response to anti-VEGF and Steroids","volume":"57","author":"Vujosevic","year":"2020","journal-title":"Acta Diabetol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.04.004_bib11","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaophthalmol.2014.2854","article-title":"Prevalence of and risk factors for diabetic macular edema in the United States","volume":"132","author":"Varma","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40942-023-00473-w","article-title":"OCT biomarkers as predictors of visual improvement in diabetic macular edema eyes receiving dexamethasone implants","volume":"9","author":"Visioli","year":"2023","journal-title":"Int J Retin Vitr"},{"key":"10.1016\/j.survophthal.2026.04.004_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8820216","article-title":"Behavior of SD-OCT detectable hyperreflective foci in diabetic macular edema patients after therapy with anti-VEGF agents and dexamethasone implants","volume":"2021","author":"Rubsam","year":"2021","journal-title":"J Diabetes Res"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061816","article-title":"Diabetic retinopathy: Pathophysiology and Treatments","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.survophthal.2026.04.004_bib15","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/14712598.2018.1545836","article-title":"Diabetic retinopathy: A Complex Pathophysiology Requiring Novel Therapeutic Strategies","volume":"18","author":"Whitehead","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.survophthal.2026.04.004_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","article-title":"Mechanisms of macular edema: Beyond the Surface","volume":"63","author":"Daruich","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"14","key":"10.1016\/j.survophthal.2026.04.004_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147585","article-title":"The role of intravitreal corticosteroids in the treatment of DME: Predictive OCT Biomarkers","volume":"23","author":"Munk","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.survophthal.2026.04.004_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213362","article-title":"Diabetic macular edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications","volume":"11","author":"Zhang","year":"2022","journal-title":"Cells"},{"issue":"26","key":"10.1016\/j.survophthal.2026.04.004_bib19","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.2174\/09298673113209990025","article-title":"Advanced glycation end products and diabetic retinopathy","volume":"20","author":"Chen","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.survophthal.2026.04.004_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2156273","article-title":"Diabetic macular edema pathophysiology: Vasogenic versus Inflammatory","volume":"2016","author":"Romero-Aroca","year":"2016","journal-title":"J Diabetes Res"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archopht.122.4.546","article-title":"The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States","volume":"122","author":"Roy","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.04.004_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.lfs.2016.08.001","article-title":"The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy","volume":"162","author":"Sorrentino","year":"2016","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pathophys.2017.07.001","article-title":"Diabetic retinopathy: Breaking the Barrier","volume":"24","author":"Eshaq","year":"2017","journal-title":"Pathophysiology"},{"issue":"8","key":"10.1016\/j.survophthal.2026.04.004_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083532","article-title":"Breaking the barrier: The Role of Proinflammatory Cytokines in BBB Dysfunction","volume":"26","author":"Gryka-Marton","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib25","article-title":"The application of structural retinal biomarkers to evaluate the effect of intravitreal ranibizumab and dexamethasone intravitreal implant on treatment of diabetic macular edema","volume":"10","author":"Ceravolo","year":"2020","journal-title":"Diagn"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"Muller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.004_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2337\/diabetes.55.03.06.db05-1349","article-title":"Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina","volume":"55","author":"Pannicke","year":"2006","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2337\/diabetes.49.6.1016","article-title":"Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels","volume":"49","author":"Badr","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.survophthal.2026.04.004_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions","volume":"34","author":"Klaassen","year":"2013","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.004_bib30","first-page":"30","article-title":"Types of diabetic macular edema assessed by optical coherence tomography","volume":"50","author":"Koleva-Georgieva","year":"2008","journal-title":"Folia Med"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.004_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13051327","article-title":"The treatment of diabetic retinal edema with intravitreal steroids: how and when","volume":"13","author":"Salvetat","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib32","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41598-023-30432-2","article-title":"Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema","volume":"13","author":"Borrelli","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.004_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/APO.0000000000000468","article-title":"Optical coherence tomography classification systems for diabetic macular edema and their associations with visual outcome and treatment responses - an updated review","volume":"11","author":"Hui","year":"2022","journal-title":"Asia Pac J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(99)00033-1","article-title":"Patterns of diabetic macular edema with optical coherence tomography","volume":"127","author":"Otani","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/bjophthalmol-2021-319587","article-title":"OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: A Real-life Retina Clinic-based Study","volume":"107","author":"Szeto","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.004_bib36","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/IAE.0000000000002992","article-title":"Detection of morphologic patterns of diabetic macular edema using a deep learning approach based on optical coherence tomography images","volume":"41","author":"Wu","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.04.004_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","article-title":"Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss","volume":"2","author":"Lee","year":"2015","journal-title":"Eye Vis"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.004_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.29271\/jcpsp.2020.02.149","article-title":"Effect of optical coherence tomography patterns on one-year outcomes of aflibercept therapy for diabetic macular edema","volume":"30","author":"Ozcaliskan","year":"2020","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib39","first-page":"241","article-title":"Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography","volume":"38","author":"Bandyopadhyay","year":"2018","journal-title":"Int Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.004_bib40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/IAE.0000000000000300","article-title":"Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema","volume":"35","author":"Liu","year":"2015","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.004_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/11206721231186649","article-title":"Validation of esaso classification of diabetic maculopathy","volume":"34","author":"Panozzo","year":"2024","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.joco.2016.08.007","article-title":"Comparison of subthreshold diode laser micropulse therapy versus conventional photocoagulation laser therapy as primary treatment of diabetic macular edema","volume":"28","author":"Fazel","year":"2016","journal-title":"J Curr Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000458539","article-title":"Guidelines for the management of diabetic macular edema by the european society of retina specialists (EURETINA)","volume":"237","author":"Schmidt-Erfurth","year":"2017","journal-title":"Ophthalmologica"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.004_bib44","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1167\/iovs.18-26215","article-title":"Anatomic response to intravitreal dexamethasone implant and baseline aqueous humor cytokine levels in diabetic macular edema","volume":"60","author":"Figueras-Roca","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"10.1016\/j.survophthal.2026.04.004_bib45","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","volume":"372","author":"Diabetic Retinopathy","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib46","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE study: Ranibizumab Monotherapy Or Combined with Laser Versus Laser Monotherapy for Diabetic Macular Edema","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/life14060725","article-title":"Switching to an intravitreal dexamethasone implant after intravitreal anti-vegf therapy for diabetic macular edema: A Review","volume":"14","author":"Vitiello","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.survophthal.2026.04.004_bib48","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2147\/OPTH.S79948","article-title":"Dexamethasone intravitreal implant in the treatment of diabetic macular edema","volume":"9","author":"Dugel","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.04.004_bib49","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2147\/OPTH.S318026","article-title":"Guidelines for the management of center-involving diabetic macular edema: treatment options and patient monitorization","volume":"15","author":"Figueira","year":"2021","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40662-021-00261-3","article-title":"Intravitreal corticosteroids for diabetic macular edema: a network meta-analysis of randomized controlled trials","volume":"8","author":"Gao","year":"2021","journal-title":"Eye Vis"},{"key":"10.1016\/j.survophthal.2026.04.004_bib51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.exer.2014.06.006","article-title":"Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model","volume":"125","author":"Mirabelli","year":"2014","journal-title":"Exp Eye Res"},{"issue":"11","key":"10.1016\/j.survophthal.2026.04.004_bib52","article-title":"Intravitreal steroids for macular edema in diabetes","volume":"11","author":"Rittiphairoj","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2026.04.004_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/989501","article-title":"Intravitreal steroids for the treatment of retinal diseases","volume":"2014","author":"Sarao","year":"2014","journal-title":"ScientificWorldJournal"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib54","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1111\/aos.13395","article-title":"Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month Outcomes of the UDBASA Study","volume":"95","author":"Sarao","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.17-22259","article-title":"Pharmacology of corticosteroids for diabetic macular edema","volume":"59","author":"Whitcup","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/IAE.0000000000000616","article-title":"Intravitreal dexamethasone implant for the treatment of refractory macular edema in retinal vascular diseases: Results of the KKESH International Collaborative Retina Study Group","volume":"36","author":"Alshahrani","year":"2016","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2026.04.004_bib57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00592-018-1151-x","article-title":"Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema","volume":"55","author":"Busch","year":"2018","journal-title":"Acta Diabetol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.004_bib58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000356413","article-title":"Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema","volume":"231","author":"Dutra Medeiros","year":"2014","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/IAE.0000000000002196","article-title":"Dexamethasone implant for diabetic macular edema in naive compared with refractory eyes: the International Retina Group Real-life 24-month Multicenter Study. The irgrel-dex study","volume":"39","author":"Iglicki","year":"2019","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.survophthal.2026.04.004_bib60","first-page":"1427","article-title":"An eighteen-month follow-up study on the effects of intravitreal dexamethasone implant in diabetic macular edema refractory to anti-VEGF therapy","volume":"9","author":"Pacella","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.04.004_bib61","unstructured":"Ozurdex, Sumary of Product Characteristics."},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041303","article-title":"Prognostic imaging biomarkers in diabetic macular edema eyes treated with intravitreal dexamethasone implant","volume":"12","author":"Costanzo","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.survophthal.2026.04.004_bib63","article-title":"Optical coherence tomography biomarkers in predicting treatment outcomes of diabetic macular edema after dexamethasone implants","volume":"9","author":"Huang","year":"2022","journal-title":"Front Med"},{"issue":"51","key":"10.1016\/j.survophthal.2026.04.004_bib64","article-title":"Characteristics of diabetic macular edema patients with serous retinal detachment","volume":"98","author":"Hwang","year":"2019","journal-title":"Med"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.004_bib65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3341\/kjo.2017.0041","article-title":"Prognostic factors for functional and anatomic outcomes in patients with diabetic macular edema treated with dexamethasone implant","volume":"32","author":"Lee","year":"2018","journal-title":"Korean J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.04.004_bib66","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1080\/02713683.2021.1878540","article-title":"Dril influences short-term visual outcome after intravitreal corticosteroid injection for refractory diabetic macular edema","volume":"46","author":"Luis","year":"2021","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2026.04.004_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9810270","article-title":"Efficacy and safety of a dexamethasone implant in patients with diabetic macular edema at tertiary centers in Korea","volume":"2016","author":"Moon","year":"2016","journal-title":"J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.004_bib68","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajo.2010.08.022","article-title":"Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy","volume":"151","author":"Murakami","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib69","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1177\/11206721241235242","article-title":"Clinical and optical coherence tomography biomarkers as prognostic factors in dexamethasone intravitreal implant for diabetic macular edema","volume":"34","author":"Oliverio","year":"2024","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib70","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.4103\/IJO.IJO_878_24","article-title":"Ultrastructural imaging biomarkers in diabetic macular edema: A Major Review","volume":"73","author":"Sen","year":"2025","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib71","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/IAE.0b013e3182a48917","article-title":"Retinal morphologic changes and concentrations of cytokines in eyes with diabetic macular edema","volume":"34","author":"Sonoda","year":"2014","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.004_bib72","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/aos.13294","article-title":"Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema","volume":"95","author":"Vujosevic","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.004_bib73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ophtha.2017.08.031","article-title":"OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant","volume":"125","author":"Zur","year":"2018","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib74","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.survophthal.2024.06.006","article-title":"Multimodal imaging in diabetic retinopathy and macular edema: An Update About Biomarkers","volume":"69","author":"Parravano","year":"2024","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib75","first-page":"CD008081","article-title":"Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy","volume":"1","author":"Virgili","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib76","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4239\/wjd.v4.i6.290","article-title":"Classification of diabetic retinopathy and diabetic macular edema","volume":"4","author":"Wu","year":"2013","journal-title":"World J Diabetes"},{"key":"10.1016\/j.survophthal.2026.04.004_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2023.101220","article-title":"Optical coherence tomography in the management of diabetic macular oedema","volume":"98","author":"Szeto","year":"2024","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.004_bib78","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ophtha.2006.06.052","article-title":"Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema","volume":"114","author":"Diabetic Retinopathy Clinical Research","year":"2007","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/11206721211026106","article-title":"External limiting membrane and ellipsoid zone structural integrity in diabetic macular edema","volume":"32","author":"Saxena","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.004_bib80","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ophtha.2008.12.039","article-title":"Optical coherence tomographic hyperreflective foci: A Morphologic Sign of Lipid Extravasation in Diabetic Macular Edema","volume":"116","author":"Bolz","year":"2009","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000342159","article-title":"Hyperreflective dots: A New Spectral-domain Optical Coherence Tomography Entity for Follow-up and Prognosis in Exudative Age-related Macular Degeneration","volume":"229","author":"Coscas","year":"2013","journal-title":"Ophthalmologica"},{"issue":"11","key":"10.1016\/j.survophthal.2026.04.004_bib82","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.ophtha.2008.04.041","article-title":"Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration","volume":"115","author":"Khanifar","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.04.004_bib83","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/491835","article-title":"Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in Vivo Study Using Spectral Domain OCT","volume":"2013","author":"Vujosevic","year":"2013","journal-title":"J Diabetes Res"},{"issue":"10","key":"10.1016\/j.survophthal.2026.04.004_bib84","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1097\/IAE.0000000000000207","article-title":"The pearl necklace sign: A Novel Spectral Domain Optical Coherence Tomography Finding in Exudative Macular Disease","volume":"34","author":"Gelman","year":"2014","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.survophthal.2026.04.004_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14093021","article-title":"Hyperreflective retinal foci (HRF): Definition and Role of an Invaluable OCT Sign","volume":"14","author":"Frizziero","year":"2025","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.004_bib86","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3341\/kjo.2022.0109","article-title":"Comparison of optical coherence tomography biomarkers between bevacizumab good responders and nonresponders who were switched to dexamethasone implant in diabetic macular edema","volume":"37","author":"Lee","year":"2023","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.04.004_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613051","article-title":"OCT hyperreflective retinal foci in diabetic retinopathy: A Semi-Automatic Detection Comparative Study","volume":"12","author":"Midena","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib88","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1111\/aos.13935","article-title":"Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers","volume":"97","author":"Bonfiglio","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12062134","article-title":"Validation of an automated artificial intelligence algorithm for the quantification of major OCT parameters in diabetic macular edema","volume":"12","author":"Midena","year":"2023","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.survophthal.2026.04.004_bib90","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.2337\/db14-0782","article-title":"Neural retinal disorganization as a robust marker of visual acuity in current and resolved diabetic macular edema","volume":"64","author":"Sun","year":"2015","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.004_bib91","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1111\/aos.14230","article-title":"Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant","volume":"98","author":"Zur","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.04.004_bib92","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/bjo-2024-326843","article-title":"Disorganisation of inner retinal layers in diabetic macular oedema: Is It Time to Standardise this OCT Biomarker?","volume":"109","author":"Danieli","year":"2025","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.04.004_bib93","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/jamaophthalmol.2015.0972","article-title":"Association oF Disorganization of Retinal Inner Layers with Vision after Resolution of Center-involved Diabetic Macular Edema","volume":"133","author":"Radwan","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.04.004_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119607","article-title":"The disorganization of retinal inner layers is correlated to muller cells impairment in diabetic macular edema: An Imaging and Omics Study","volume":"24","author":"Midena","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib95","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1111\/aos.14297","article-title":"Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema","volume":"98","author":"Podkowinski","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib96","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/11206721241248682","article-title":"Retinal OCT biomarkers associated with reading performance in patients with persistent vs. resolved diabetic macular edema","volume":"35","author":"Ricardi","year":"2025","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib97","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/IAE.0000000000001687","article-title":"Optical coherence tomography baseline predictors for initial best-corrected visual acuity response to intravitreal anti-vascular endothelial growth factor treatment in eyes with diabetic macular edema: The Chartres Study","volume":"38","author":"Santos","year":"2018","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.004_bib98","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/bjophthalmol-2016-308726","article-title":"Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant","volume":"101","author":"Iacono","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.04.004_bib99","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6639418","article-title":"Optical coherence tomography predictors of favorable functional response in naive diabetic macular edema eyes treated with dexamethasone implants as a first-line agent","volume":"2021","author":"Meduri","year":"2021","journal-title":"J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.04.004_bib100","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.oret.2019.06.010","article-title":"Higher-order assessment of OCT in diabetic macular edema from the VISTA study: Ellipsoid Zone Dynamics and the Retinal Fluid Index","volume":"3","author":"Ehlers","year":"2019","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2026.04.004_bib101","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8117650","article-title":"Ellipsoid zone integrity and visual acuity changes during diabetic macular edema therapy: A Longitudinal Study","volume":"2021","author":"Kessler","year":"2021","journal-title":"J Diabetes Res"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.004_bib102","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/s41433-020-1100-0","article-title":"Sequential restoration of external limiting membrane and ellipsoid zone after intravitreal anti-VEGF therapy in diabetic macular oedema","volume":"35","author":"De","year":"2021","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib103","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1120672119880394","article-title":"An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification","volume":"30","author":"Panozzo","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib104","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2022-001214","article-title":"Prevalence and clinical implications of subretinal fluid in retinal diseases: a real-world cohort study","volume":"8","author":"Park","year":"2023","journal-title":"BMJ Open Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.04.004_bib105","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s00417-021-05083-6","article-title":"Intracystic hyperreflective material in centre-involving diabetic macular oedema","volume":"259","author":"Venkatesh","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib106","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10792-018-0874-6","article-title":"Vitreous IL-8 and VEGF levels in diabetic macular edema with or without subretinal fluid","volume":"39","author":"Yenihayat","year":"2019","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.004_bib107","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tjo.2012.05.001","article-title":"Development of vitreomacular interface abnormality in patients with diabetic macular edema","volume":"2","author":"Chang","year":"2012","journal-title":"Taiwan J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.004_bib108","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/eye.2016.317","article-title":"The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF","volume":"31","author":"Chang","year":"2017","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib109","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/jop.2011.0070","article-title":"Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment","volume":"28","author":"Wu","year":"2012","journal-title":"J Ocul Pharm Ther"},{"issue":"9","key":"10.1016\/j.survophthal.2026.04.004_bib110","doi-asserted-by":"crossref","first-page":"OCT348","DOI":"10.1167\/iovs.15-18782","article-title":"New insights into microaneurysms in the deep capillary plexus detected by optical coherence tomography angiography in diabetic macular edema","volume":"57","author":"Hasegawa","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.04.004_bib111","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2147\/OPTH.S232549","article-title":"Real life experience of dexamethasone implant in refractory diabetic macular oedema","volume":"13","author":"Karttunen","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.004_bib112","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/ICB.0b013e31828eef49","article-title":"Solid-appearing retinal cysts in diabetic macular edema: A Novel Optical Coherence Tomography Finding","volume":"7","author":"Liang","year":"2013","journal-title":"Retin Cases Brief Rep"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.004_bib113","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ajo.2011.03.033","article-title":"Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema","volume":"152","author":"Sohn","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.04.004_bib114","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2147\/OPTH.S257775","article-title":"A real-world study of dexamethasone implant in treatment-naive patients with diabetic macular edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome","volume":"14","author":"Vadala","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.004_bib115","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1120672120925788","article-title":"Short-term outcomes of intravitreal dexamethasone in relation to biomarkers in diabetic macular edema","volume":"31","author":"Narnaware","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.04.004_bib116","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaophthalmol.2018.3848","article-title":"Correlation of central retinal thickness and visual acuity in diabetic macular edema","volume":"136","author":"Deak","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.04.004_bib117","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jamaophthalmol.2019.1963","volume":"137","author":"Bressler","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.04.004_bib118","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3459164","article-title":"Association between hyperreflective foci on spectral-domain optical coherence tomography and early recurrence of diabetic macular edema after intravitreal dexamethasone implantation","volume":"2019","author":"Kim","year":"2019","journal-title":"J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.04.004_bib119","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.oret.2019.03.015","article-title":"Effect of baseline subretinal fluid on treatment outcomes in VIVID-DME and VISTA-DME studies","volume":"3","author":"Korobelnik","year":"2019","journal-title":"Ophthalmol Retin"},{"issue":"8","key":"10.1016\/j.survophthal.2026.04.004_bib120","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00417-018-4009-6","article-title":"Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy","volume":"256","author":"Mikhail","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.04.004_bib121","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00417-022-05595-9","article-title":"Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy","volume":"260","author":"O'Fee","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.004_bib122","article-title":"Predictive value of optical coherence tomography biomarkers in patients with persistent diabetic macular edema undergoing cataract surgery combined with a dexamethasone intravitreal implant","volume":"12","author":"Fasolino","year":"2025","journal-title":"Bioeng"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.004_bib123","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ophtha.2025.07.038","article-title":"Baseline OCT biomarkers associated with visual acuity in diabetic macular edema: A Systematic Review and Meta-analysis","volume":"133","author":"Nanji","year":"2026","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.04.004_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2024.108253","article-title":"Artificial intelligence in retinal screening using OCT images: A Review of the Last Decade (2013-2023)","volume":"254","author":"Akpinar","year":"2024","journal-title":"Comput Methods Prog Biomed"},{"key":"10.1016\/j.survophthal.2026.04.004_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1097291","article-title":"Artificial intelligence method based on multi-feature fusion for automatic macular edema (ME) classification on spectral-domain optical coherence tomography (SD-OCT) images","volume":"17","author":"Gan","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.survophthal.2026.04.004_bib126","doi-asserted-by":"crossref","DOI":"10.1056\/AIoa2400091","article-title":"Advancing diabetic macular edema detection from 3D optical coherence tomography scans: Integrating Privacy-Preserving AI and Generalizability Techniques \u2014 A Prospective Validation in Vietnam","volume":"1","author":"Nguyen","year":"2024","journal-title":"NEJM AI"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:02:27Z","timestamp":1789070547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625726000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":126,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0039625726000561"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.04.004","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optical coherence tomography biomarkers in patients with diabetic macular edema treated with dexamethasone implants","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}